Product Information
NEBIVOLOL 10 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1414 per EA under NDC 00904749904. Its NADAC has been published 67 times since Jun 25, 2025.
FDA first approved this application on Apr 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the nebivolol market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904749904
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NEBIVOLOLApproval Type
Generic (ANDA)
FDA Application
ANDA212682FDA Approved
4/7/2022
TE Code
AB
On Market Since
2/24/2025
Pharmacological Classes
Price Statistics
The NADAC for NEBIVOLOL 10 MG TABLET has been published 67 times since Jun 25, 2025, and over the history we have for it it has declined 6.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1414 per EA |
|---|---|
| All-time high | $0.1512 (Jul 16, 2025) |
| All-time low | $0.1340 (Mar 18, 2026) |
| 52-week high | $0.1474 |
| 52-week low | $0.1340 |
| Median price | $0.1402 |
| Average price | $0.1413 |
| Largest weekly change | +5.1% (Jun 17, 2026) |
| Weeks tracked | 67 |
| Tracking since | Jun 25, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nebivolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEBIVOLOL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEBIVOLOL 10 MG TABLET, manufactured by Major Pharmaceuticals, is $0.1414 per EA (NDC 00904749904), effective Sep 30, 2026.
How has the price of NEBIVOLOL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEBIVOLOL 10 MG TABLET has declined 6.4%. It has been tracked across 67 weekly CMS publications since Jun 25, 2025.
What are the highest and lowest recorded NADAC prices for NEBIVOLOL 10 MG TABLET?
Since Jun 25, 2025, the NADAC for NEBIVOLOL 10 MG TABLET has ranged from a low of $0.1340 (Mar 18, 2026) to a high of $0.1512 (Jul 16, 2025), with a median of $0.1402 per EA.
Are there cheaper alternatives to NEBIVOLOL 10 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NEBIVOLOL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NEBIVOLOL 10 MG TABLET?
NEBIVOLOL 10 MG TABLET (NDC 00904749904) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.